Diamedica Therapeutics logo

Diamedica Therapeutics share price today

(DMAC)

Diamedica Therapeutics share price is $5.26 & ₹448.14 as on 25 Dec 2024, 2.30 'hrs' IST

$5.26

-0.12

(-2.14%)

Market is closed - opens 8 PM, 26 Dec 2024

View live Diamedica Therapeutics share price in Dollar and Rupees. Guide to invest in Diamedica Therapeutics from India. Also see the sentimental analysis on Indian investors investing in Diamedica Therapeutics. Get details on the Indian mutual funds that are investing in Diamedica Therapeutics. Get Analyst recommendations and forecasts along with all the Diamedica Therapeutics's financials.

Diamedica Therapeutics share price movements

  • Today's Low: $5.08
    Today's High: $5.55

    Day's Volatility :8.47%

  • 52 Weeks Low: $2.14
    52 Weeks High: $6.41

    52 Weeks Volatility :66.61%

Diamedica Therapeutics Returns

PeriodDiamedica Therapeutics IncIndex (Russel 2000)
3 Months
22.33%
0.0%
6 Months
72.46%
0.0%
1 Year
82.01%
0.0%
3 Years
53.35%
-21.1%

Diamedica Therapeutics Key Statistics

in dollars & INR

Previous Close
$5.375
Open
$5.35
Today's High
$5.55
Today's Low
$5.0801
Market Capitalization
$224.9M
Today's Volume
$50.5K
52 Week High
$6.41
52 Week Low
$2.14
Revenue TTM
$0.0
EBITDA
$-22.4M
Earnings Per Share (EPS)
$-0.56
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-35.18%

How to invest in Diamedica Therapeutics from India?

It is very easy for Indian residents to invest directly in Diamedica Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Diamedica Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Diamedica Therapeutics or DMAC on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Diamedica Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Diamedica Therapeutics shares which would translate to 0.162 fractional shares of Diamedica Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Diamedica Therapeutics, in just a few clicks!

Returns in Diamedica Therapeutics for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Diamedica Therapeutics investment value today

Current value as on today

₹1,84,246

Returns

₹84,246

(+84.25%)

Returns from Diamedica Therapeutics Stock

₹82,007 (+82.01%)

Dollar Returns

₹2,239 (+2.24%)

Indian investors sentiment towards Diamedica Therapeutics

0%

Period: Sep 26, 2024 to Dec 25, 2024. Change in 30 Days versus previous period

Search volume for Diamedica Therapeutics on INDmoney from India has grown in the last 30 days as on Dec 26, 2024. 0% more investors are searching Diamedica Therapeutics in the last 30 days versus the previous period.

Global Institutional Holdings in Diamedica Therapeutics

  • Cooperman Leon G

    3.54%

  • Vanguard Group Inc

    2.45%

  • First Manhattan Co. LLC

    1.96%

  • PARAGON Assoc & PARAGON Assoc II JV

    1.13%

  • Bleichroeder LP

    0.89%

  • Geode Capital Management, LLC

    0.72%

Analyst Recommendation on Diamedica Therapeutics

Buy

    88%Buy

    11%Hold

    0%Sell

Based on 9 Wall street analysts offering stock ratings for Diamedica Therapeutics(by analysts ranked 0 to 5 stars)

Based on 9 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
8
8
8
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Diamedica Therapeutics

What analysts predicted

Upside of 33.08%

Current:

$5.26

Target:

$7.00

Insights on Diamedica Therapeutics

  • Price Movement

    In the last 6 months, DMAC stock has moved up by 77.7%
  • Increasing Revenue

    Revenue is up for the last 3 quarters, 13.0K → 30.83M (in $), with an average increase of 91.3% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -5.11M → -6.27M (in $), with an average decrease of 22.6% per quarter

Diamedica Therapeutics Technicals Summary

Sell

Neutral

Buy

Diamedica Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Diamedica Therapeutics Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Diamedica Therapeutics Inc
3.54%
72.46%
82.01%
53.35%
9.81%
Regeneron Pharmaceuticals, Inc.
-5.12%
-32.01%
-18.29%
12.56%
91.19%
Biontech Se
-3.72%
41.99%
6.11%
-55.22%
226.93%
Alnylam Pharmaceuticals, Inc.
-3.99%
-1.52%
23.75%
50.98%
112.09%
Vertex Pharmaceuticals Incorporated
-12.61%
-13.61%
0.03%
83.58%
86.41%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Diamedica Therapeutics Inc
NA
NA
NA
-0.59
-0.35
-0.24
NA
1.35
Regeneron Pharmaceuticals, Inc.
17.67
17.67
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.06
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Diamedica Therapeutics Inc
Buy
$224.9M
9.81%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$78.5B
91.19%
17.67
33.61%
Biontech Se
Buy
$27.4B
226.93%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$31.4B
112.09%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$105.1B
86.41%
32.84
-4.51%

About Diamedica Therapeutics

diamedica therapeutics is a clinical-stage biopharmaceutical company that is developing innovative treatments where there is significant unmet clinical need or where no current therapies are available with the focus on neurological and kidney diseases. for more information please visit www.diamedica.com.
Organization
Diamedica Therapeutics
Employees
18
CEO
Mr. Dietrich John Pauls MBA
Industry
Health Technology

Management People of Diamedica Therapeutics

NameTitle
Mr. Dietrich John Pauls MBA
President, CEO & Director
Mr. Scott Kellen CPA
CFO & Corporate Secretary
Dr. Ambarish Shah Ph.D.
Chief Technology Officer
Mr. Dominic R. Cundari
Chief Commercial Officer
Mr. David J. Wambeke
Chief Business Officer
Dr. Lorianne K. Masuoka M.D.
Chief Medical Officer

Important FAQs about investing in Diamedica Therapeutics from India :

What is Diamedica Therapeutics share price today?

Diamedica Therapeutics share price today stands at $5.26, Open: $5.35 ; Previous Close: $5.38 ; High: $5.55 ; Low: $5.08 ; 52 Week High: $6.41 ; 52 Week Low: $2.14. The stock opens at $5.35, after a previous close of $5.38. The stock reached a daily high of $5.55 and a low of $5.08, with a 52-week high of $6.41 and a 52-week low of $2.14.

Can Indians buy Diamedica Therapeutics shares?

Yes, Indians can invest in the Diamedica Therapeutics (DMAC) from India.

With INDmoney, you can buy Diamedica Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Diamedica Therapeutics at zero transaction cost.

How can I buy Diamedica Therapeutics shares from India?

It is very easy to buy Diamedica Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Diamedica Therapeutics be purchased?

Yes, you can buy fractional shares of Diamedica Therapeutics with INDmoney app.

What are the documents required to start investing in Diamedica Therapeutics stocks?

To start investing in Diamedica Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Diamedica Therapeutics

Today’s highest price of Diamedica Therapeutics (DMAC) is $5.55.

Today’s lowest price of Diamedica Therapeutics (DMAC) is $5.08.

What is today's market capitalisation of Diamedica Therapeutics

Today's market capitalisation of Diamedica Therapeutics DMAC is 224.9M

What is the 52 Week High and Low Range of Diamedica Therapeutics

  • 52 Week High

    $6.41

  • 52 Week Low

    $2.14

What are the historical returns of Diamedica Therapeutics?

  • 1 Month Returns

    3.54%

  • 3 Months Returns

    72.46%

  • 1 Year Returns

    82.01%

  • 5 Years Returns

    9.81%

Who is the Chief Executive Officer (CEO) of Diamedica Therapeutics

Mr. Dietrich John Pauls MBA is the current Chief Executive Officer (CEO) of Diamedica Therapeutics.